Table 1.
Demographic data: non-severe and severe LVV patients
| Non-severe LVV (N = 6) | Severe LVV (N = 9) | p value | |
|---|---|---|---|
| LVV subtype | |||
| Giant cell arteritis | 5 (83%) | 4 (44%) | 0.29 |
| Takayasu arteritis | 1 (17%) | 5 (56%) | 0.29 |
| Immunosuppression | |||
| Steroids | 1 (17%) | 2 (22%) | 1.00 |
| Biologic | 1 (17%) | 2 (22%) | 1.00 |
| Steroid + Biologic | 3 (50%) | 1 (11%) | 0.24 |
| Atherosclerosis risk factors | |||
| Smoking | 3 (50%) | 1 (11%) | 0.24 |
| Diabetes | 0 (0%) | 0 (0%) | 1.00 |
| Hypertension | 2 (33%) | 6 (67%) | 0.31 |
| BMI > 25 kg/m2 | 4 (67%) | 2 (22%) | 0.14 |
| Hyperlipidemia | 4 (67%) | 5 (56%) | 1.00 |
| 2 or more risk factors | 4 (67%) | 6 (67%) | 1.00 |
LVV large vessel vasculitis, BMI body mass index